이상반응 보고
| VAERS ID | 1627513 |
|---|---|
| 성별 | 여성 |
| 나이 | 15세 |
| 주 코드 | TX |
| 제약회사 | MODERNA |
| 로트 번호 | 022B21A |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-06-11 |
| 발병일 | 2021-06-11 |
| 상태 | 회복 |
증상
- 부적절한 연령의 환자에게 투여된 제품(Product administered to patient of inappropriate age)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
15 year old female who received her first dose of the Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no.
022B21A) for COVID-19 vaccination.
No Medical History information was reported.
On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.
On 11-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine).
On 11-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine) had resolved.
The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No concomitant medications were reported.
No treatment information was provided.